Skip to main content

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 4,161–4,180 of 17,937 drug recalls

Drug Recall Terminated Historical recordClass III

T-105, Papaverine 30 mg/mL Phentolamine 1 mg/mL PGE 10 mcg/mL packaged as a) 5 mL Multi-dose NDC 73198-0005-05; b) 10 mL Multi-dose NDC 73198-0005-10; Each ML contains: 0.5% Chlorobutanol NF, 0.0005% Edetate Disodium Dihydrate USP, 1.84% Benzyl Alcohol NF, 5% Mannitol USP, 1% Sodium Metabisulfite NF, 0.5% Ethyl Alcohol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835.

by Olympia Compounding Pharmacy dba Olympia Pharmacy

Reason
Super Potent
Recall initiated
March 8, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA including Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass III

Formula F9, Papaverine 0.9 mg/mL, Phentolamine 0.1 mg/mL, PGE 20 mcg/mL, Atropine 0.01 mg/mL, Multi-Dose 10 mL vial, Each ML contains: 0.5% Chlorobutanol NF, 0.005% Edetate Disodium Dihydrate USP, 2.74% Benzyl Alcohol NF, 5% Mannitol USP, 1% Sodium Metabisulfite NF, 1% Ethyl Alcohol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0004-10

by Olympia Compounding Pharmacy dba Olympia Pharmacy

Reason
Sub Potent
Recall initiated
March 8, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA including Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

NAD+ Nicotinamide Adenine Dinucleotide, Lyophilized powder for reconstitution, Multi-Dose 500 mg per vial, Each ML contains: 0.288% Sodium Phosphate Monobasic USP, 0.42% Sodium Phosphate Dibasic USP, 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals 6700 Conroy Rd., Ste. 155, Orlando, FL 32835 NDC: 73198-0083-00

by Olympia Compounding Pharmacy dba Olympia Pharmacy

Reason
Product found to be Sub Potent or Exceeded reconstitution time
Recall initiated
March 8, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA including Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

Sermorelin Acetate Lyophilized powder for reconstitution, Multi-Dose 9 mg per vial, Each ML contains: 5% Mannitol USP, Sterile Water for Injection USP, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0059-00

by Olympia Compounding Pharmacy dba Olympia Pharmacy

Reason
Sub Potent
Recall initiated
March 8, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA including Puerto Rico.

View recall →

Drug Recall Terminated Historical recordClass II

TheraTears Extra (sodium carboxymethylcellulose) 0.25% Lubricant Eye Drops, 30 Sterile Single-Use Vials per box, Akorn Consumer Health, A Division of Akorn, Inc., Ann Arbor, MI 48105. NDC 58790-010-30

by Akorn, Inc.

Reason
Lack of Assurance of Sterility
Recall initiated
September 8, 2021
Reported by FDA
March 30, 2022
Distribution
Nationwide within theUSA

View recall →

Drug Recall Terminated Historical recordClass II

ROCK TOWN - DISTILLERY - HAND SANITIZER, Alcohol Antiseptic 70%, Topical Solution packaged in a) 375 mL (12.7 fl. oz.), NDC 74492-0002-1; b) 3785 mL/1 gallon NDC 74492-0002-2; c) 236 mL/8 oz. NDC 74492-0002-3; d) 473 mL/16 oz. NDC 74492-0002-4; Made in USA Rock Town Distillery, 1201 Main Street Little Rock, Arkansas 72202

by Rock Town Distillery, Inc.

Reason
CGMP Deviations: FDA analysis found product to contain acetal and acetaldehyde above specification limits.
Recall initiated
March 10, 2022
Reported by FDA
March 30, 2022
Distribution
Distributed in Arkansas USA

View recall →

Drug Recall Terminated Historical recordClass II

Diclofenac Sodium Topical Solution 1.5%, 150 mL, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534 Mfg. For SOLA Pharmaceuticals Baton Rouge, LA, NDC 61919-675-05

by Direct Rx

Reason
Defective Container: Leaking containers.
Recall initiated
December 7, 2021
Reported by FDA
March 30, 2022
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

Epinephrine Injection 8 mg per 250 mL in 0.9% Sodium Chloride, 8mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-814-15

by Athenex Pharma Solutions, LLC

Reason
Defective container
Recall initiated
March 14, 2022
Reported by FDA
March 30, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Phenylephrine HCl Injection in 0.9% Sodium Chloride, 20 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-491-15

by Athenex Pharma Solutions, LLC

Reason
Defective container
Recall initiated
March 14, 2022
Reported by FDA
March 30, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Phenylephrine HCl Injection 50 mg per 250 mL in 0.9% Sodium Chloride, 50 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-494-15

by Athenex Pharma Solutions, LLC

Reason
Defective container
Recall initiated
March 14, 2022
Reported by FDA
March 30, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Phenylephrine HCl Injection 40 mg per 250 mL in 0.9% Sodium Chloride, 40 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-493-15

by Athenex Pharma Solutions, LLC

Reason
Defective container
Recall initiated
March 14, 2022
Reported by FDA
March 30, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Norepinephrine Bitartrate Injection 8 mg per 250 mL in 0.9% Sodium Chloride, 8 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-475-15

by Athenex Pharma Solutions, LLC

Reason
Defective container
Recall initiated
March 14, 2022
Reported by FDA
March 30, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Norepinephrine Bitartrate Injection 16 mg per 250 mL added to 0.9% Sodium Chloride, 16 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-476-15

by Athenex Pharma Solutions, LLC

Reason
Defective container
Recall initiated
March 14, 2022
Reported by FDA
March 30, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Norepinephrine Bitartrate Injection 4mg per 250 mL in 0.9% Sodium Chloride, 4 mg, 250 mL excel bag, Rx only, Athenex Pharma Solutions, LLC, Clarence, NY, 14031, NDC 76154-474-15

by Athenex Pharma Solutions, LLC

Reason
Defective container
Recall initiated
March 14, 2022
Reported by FDA
March 30, 2022
Distribution
USA nationwide.

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine Ointment USP, 5%, Net Wt 35.44 g (1 1/4 Oz) tube, Rx Only, Manufactured for: Hi-Tech Pharmacal Co., Inc., Amityville, NY 11701, NDC 50383-341-35.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine Cream 4%, Net Wt. 30 grams tube, Distributed by: RUGBY LABORATORIES, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152, NDC 0536-1281-28.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Hydrocortisone Butyrate Lotion, 0.1%, 4 fl oz (118 mL) bottle, Rx only, Manufactured for: SOLA Pharmaceuticals, Baton Rouge, LA 70809, NDC 70512-032-04.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Gentamicin Sulfate Cream USP, 0.1%, packaged in 30 grams tubes, Rx Only, Manufactured for: SOLA Pharmaceuticals, LLC, Baton Rouge, LA 70810, NDC 70512-036-30.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Diflorasone Diacetate Ointment USP, 0.05%, Net Wt 60 g tubes, Rx only, Manufactured by: Teligent Pharm, Inc., Buena, New Jersey 08310, NDC 52565-063-60.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Drug Recall Terminated Historical recordClass II

Clobetasol Propionate Cream USP, 0.05%, packaged in 60 grams tube, Rx only, Manufactured for SOLA Pharmaceuticals, Baton Rouge, LA 70809; NDC 70512-028-60.

by Teligent Pharma, Inc.

Reason
cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.
Recall initiated
March 15, 2022
Reported by FDA
March 30, 2022
Distribution
Nationwide in the USA and Puerto Rico

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.